Kolon Biotech
Kolon Biotech, a vital entity within the Kolon Group, leverages over 20 years of expertise in the fields of Cell & Gene therapy and Exosome therapy.
Description
KOLON Biotech is a trusted CDMO specialized in cell and gene therapy. Our team of experts, with extensive experience in producing cell and gene therapy as well as exosome therapy, oversees the entire manufacturing process. We are dedicated to operational excellence in GMP manufacturing and quality assurance, ensuring value delivery to our clients. KOLON Biotech's end-to-end CDMO service offer solutions aimed at shortening time-to-market, enhancing efficiency, and alleviating regulatory burdens.
Type of Drugs Manufactured:
Cell & Gene Therapy
CDMO Services:
Clinical Trials materials and logistics
No. of Manufacturing Facilities:
2
Facilities Locations:
East Asia
Regulatory Approvals for facilities:
GMP
Manufacturing Technologies:
Sterile Vials
Current Capacity:
: Maximum capacity of 2 Suites in B1 Plant is total 1,920 Layer. Suite 1 can take 48 Culture Vessel with 10 Layers of Cell Factory and produce 368 vials per batch. Otherwise, Suite 2 accommodates 144 Culture Vessels with 10 Layers of Cell Factory, having 1,104 vials per batch. With those capacity, filling process is done with 800 vials per hour in our Filling Room.
2. B2 Plant
: B2 Plant is optimized for mass production, composed of 4 Cell Suites with Maximum capacity of 10,240 Layers. 64 Culture Vessels with 40 Layers can be made in each Cell Suites with maximum 1,966 vials per batch. In response to Layer capacity, 12,000 vials can be filled each hour in our Filling Room.
There is Future Area in B2 Plant which has infinite potential to be flexibly customized to client requests.
Who are the ideal customers for your services?:
- Research Institutes, Biotech companies, Biopharmaceutical companies that has plans to perform clinical trials in Korea, Japan, and USA.
With a commitment to excellence and innovation, Kolon Biotech continues to set the standard in the biotechnology sector. For additional information, please visit kolon.com.